Ware RE - Search Results

1

Hydroxyurea for children with sickle cell disease.

Heeney MM, Ware RE. Heeney MM, et al. Among authors: ware re. Pediatr Clin North Am. 2008 Apr;55(2):483-501, x. doi: 10.1016/j.pcl.2008.02.003. Pediatr Clin North Am. 2008. PMID: 18381097 Review.

2

UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia.

Heeney MM, Howard TA, Zimmerman SA, Ware RE. Heeney MM, et al. Among authors: ware re. J Lab Clin Med. 2003 Apr;141(4):279-82. doi: 10.1067/mlc.2003.28. J Lab Clin Med. 2003. PMID: 12677174 Clinical Trial.

3

Increased expression of anti-apoptosis genes in peripheral blood cells from patients with paroxysmal nocturnal hemoglobinuria.

Heeney MM, Ormsbee SM, Moody MA, Howard TA, DeCastro CM, Ware RE. Heeney MM, et al. Among authors: ware re. Mol Genet Metab. 2003 Apr;78(4):291-4. doi: 10.1016/s1096-7192(03)00047-7. Mol Genet Metab. 2003. PMID: 12706380

4

Childhood autoimmune cytopenia secondary to unsuspected common variable immunodeficiency.

Heeney MM, Zimmerman SA, Ware RE. Heeney MM, et al. Among authors: ware re. J Pediatr. 2003 Nov;143(5):662-5. doi: 10.1067/S0022-3476(03)00445-1. J Pediatr. 2003. PMID: 14615742

5

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease.

Zimmerman SA, Schultz WH, Davis JS, Pickens CV, Mortier NA, Howard TA, Ware RE. Zimmerman SA, et al. Among authors: ware re. Blood. 2004 Mar 15;103(6):2039-45. doi: 10.1182/blood-2003-07-2475. Epub 2003 Nov 20. Blood. 2004. PMID: 14630791 Free article. Clinical Trial.

6

Chemical and functional analysis of hydroxyurea oral solutions.

Heeney MM, Whorton MR, Howard TA, Johnson CA, Ware RE. Heeney MM, et al. Among authors: ware re. J Pediatr Hematol Oncol. 2004 Mar;26(3):179-84. doi: 10.1097/00043426-200403000-00007. J Pediatr Hematol Oncol. 2004. PMID: 15125610

7

Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.

Ware RE, Zimmerman SA, Sylvestre PB, Mortier NA, Davis JS, Treem WR, Schultz WH. Ware RE, et al. J Pediatr. 2004 Sep;145(3):346-52. doi: 10.1016/j.jpeds.2004.04.058. J Pediatr. 2004. PMID: 15343189

8

Enalapril and hydroxyurea therapy for children with sickle nephropathy.

Fitzhugh CD, Wigfall DR, Ware RE. Fitzhugh CD, et al. Among authors: ware re. Pediatr Blood Cancer. 2005 Dec;45(7):982-5. doi: 10.1002/pbc.20296. Pediatr Blood Cancer. 2005. PMID: 15704213

9

Hemoglobinopathies mimicking Hb S/beta-thalassemia: Hb S/S with alpha-thalassemia and Hb S/Volga.

Luo HY, Heeney M, Wang WC, Eung SH, Ware RE, Steinberg MH, Chui DH. Luo HY, et al. Among authors: ware re. Am J Hematol. 2006 May;81(5):361-5. doi: 10.1002/ajh.20562. Am J Hematol. 2006. PMID: 16628724 Free article.

10

Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia.

Zimmerman SA, Schultz WH, Burgett S, Mortier NA, Ware RE. Zimmerman SA, et al. Among authors: ware re. Blood. 2007 Aug 1;110(3):1043-7. doi: 10.1182/blood-2006-11-057893. Epub 2007 Apr 11. Blood. 2007. PMID: 17429008 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters